BamSEC and AlphaSense Join Forces
Learn More

CannaPharmaRx Inc

OTC: CPMD    
Share price (12/23/24): $0.01    
Market cap (12/23/24): $5.963 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.6
from 10-K 11 pages Master Agreement
12/34/56
EX-10.1
from 8-K 1 page CannaPharmaRx Appoints Dean Medwid as New CEO
12/34/56
EX-10.3
from S-1/A 5 pages Securities Purchase Agreement
12/34/56
EX-10.2
from S-1/A 11 pages Registration Rights Agreement
12/34/56
EX-10.1
from S-1/A 24 pages Purchase Agreement
12/34/56
EX-10.3
from S-1/A 5 pages Securities Purchase Agreement
12/34/56
EX-10.2
from S-1/A 11 pages Registration Rights Agreement
12/34/56
EX-10.1
from S-1/A 24 pages Purchase Agreement
12/34/56
EX-10.5
from 8-K 4 pages Consulting and Broker Agreement
12/34/56
EX-10.5
from 8-K 20 pages Amendment of Agreement of Purchase and Sale
12/34/56
EX-10.5
from 8-K 18 pages Common Stock Purchase Agreement
12/34/56
EX-10.5
from 8-K 31 pages Limited Liability Company Membership Interest Purchase Agreement by and Between Bristol Capital Investors, LLC a Delaware Limited Liability Company as Seller and CannaPharmaRx Inc. a Delaware Corporation as Buyer Dated as of June 24, 2020
12/34/56
EX-10.6
from 8-K 7 pages Amending Agreement No. 3 to Share Purchase Agreement
12/34/56
EX-10.1
from 8-K 21 pages Securities Purchase Agreement
12/34/56
EX-10.5
from 8-K 5 pages Amending Agreement No. 2 to Share Purchase Agreement
12/34/56
EX-10.5
from 8-K 6 pages Amending Agreement to Share Purchase Agreement
12/34/56
EX-10.5
from 8-K 14 pages Heads of Agreement
12/34/56
EX-10.4
from 8-K 42 pages CannaPharmaRx Canada Corp. - And – Cannapharmarx, Inc. - And – Share Purchase Agreement June 11, 2019
12/34/56
EX-10.3
from 10-Q 4 pages Commercial Lease Agreement
12/34/56
EX-10.5
from 10-K 5 pages Cannapharmarx, Inc. (A Delaware Corporation) 12% Convertible Debenture Due on or Before July __, 2019
12/34/56